Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.09% slipped 1.86% to $175.50 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.36% falling 4.04% to 3,923.68 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.23% falling 3.57% to 31,490.07. The stock's fall snapped a two-day winning streak. Johnson & Johnson closed $11.19 below its 52-week high ($186.69), which the company reached on April 25th.
The stock underperformed when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.77% fell 0.01% to $322.59, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.53% fell 0.97% to $92.10, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.15% fell 1.83% to $50.40. Trading volume (8.5 M) eclipsed its 50-day average volume of 7.7 M.